Cabozantinib for Brain Metastases in Patients With RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma
JAMA Oncol 2021 Oct 21;[EPub Ahead of Print], L Hirsch, N Martinez Chanza, S Farah, W Xie, R Flippot, DA Braun, N Rathi, J Thouvenin, KA Collier, E Seront, G de Velasco, H Dzimitrowicz, B Beuselinck, W Xu, IA Bowman, ET Lam, B Abuqayas, MA Bilen, A Varkaris, Y Zakharia, MR Harrison, A Mortazavi, P Barthélémy, N Agarwal, RR McKay, PK Brastianos, KM Krajewski, L Albigès, LC Harshman, TK ChoueiriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.